Detalhe da pesquisa
1.
Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy.
BMC Cancer
; 23(1): 136, 2023 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36765293
2.
Real-life experience of patients with sarcomatoid renal cell carcinoma: a multicenter retrospective study.
Neoplasma
; 70(1): 158-165, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36620878
3.
Clinical Features and Prognostic Factors of Metastatic Non-Clear Cell Renal Cell Carcinoma: A Multicenter Study from the Turkish Oncology Group Kidney Cancer Consortium.
Urol Int
; 107(6): 595-601, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36996793
4.
Nivolumab in metastatic renal cell carcinoma: results from the Turkish Oncology Group Kidney Cancer Consortium database.
Future Oncol
; 17(35): 4861-4869, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34726480
5.
Trimester-specific reference intervals of thyroid function tests in Turkish pregnants.
Gynecol Endocrinol
; 36(5): 413-416, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-31532263
6.
Neutrophil-lymphocyte ratio as a prognostic factor for survival in patients with advanced renal cell carcinoma (Turkish Oncology Group Study).
J Oncol Pharm Pract
; 26(7): 1583-1589, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32054412
7.
The relationship between prognostic nutritional index and treatment response in patients with metastatic renal cell cancer.
J Oncol Pharm Pract
; 26(5): 1110-1116, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-31653193
8.
The neutrophil-lymphocyte ratio and its relationship with insulin resistance in obesity
Turk J Med Sci
; 49(1): 245-248, 2019 Feb 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30761879
9.
Correction: Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy.
BMC Cancer
; 23(1): 192, 2023 Feb 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36849943
10.
Renal function improves with the treatment of hypothyroidism.
Endocr Res
; 42(3): 246-251, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28287838
11.
Treatment outcomes and prognostic factors in patients with driver mutant non-small cell lung cancer and de novo brain metastases.
Sci Rep
; 14(1): 5820, 2024 03 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38461209
12.
The Potential Prognostic Marker TyG Index Predicts Time to Brain Metastasis at HER2 Positive Breast Cancer.
Cancer Manag Res
; 15: 311-317, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36994110
13.
External Validation of a Novel Risk Model in Patients With Favorable Risk Renal Cell Carcinoma Defined by International Metastatic Renal Cell Carcinoma Database Consortium (IMDC): Results From the Turkish Oncology Group Kidney Cancer Consortium (TKCC) Database.
Clin Genitourin Cancer
; 21(1): 175-182, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35970759
14.
Ideal Lymph Node Number for Ovarian Malignancies.
Cureus
; 14(1): e20869, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-35145776
15.
High Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio and Low Lymphocyte Levels Are Correlated With Worse Pathological Complete Response Rates.
Cureus
; 14(3): e22972, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35415045
16.
Platelet-to-Lymphocyte Ratio as an Indicator to Predict Decreased Carbon Monoxide Diffusion of the Lung in Patients with Testicular Cancer.
J Coll Physicians Surg Pak
; 32(3): 369-372, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35148592
17.
Clinicopathological features of non-carcinoid malignant epithelial appendix tumors and risk factors for recurrence, single-center experience.
Indian J Cancer
; 2022 Oct 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36861708
18.
The relationship between pan-immune-inflammation value and survival outcomes in patients with metastatic renal cell carcinoma treated with nivolumab in the second line and beyond: a Turkish oncology group kidney cancer consortium (TKCC) study.
J Cancer Res Clin Oncol
; 148(12): 3537-3546, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35616728
19.
The relationship between systemic immune inflammation index and survival in patients with metastatic renal cell carcinomatreated withtyrosine kinase inhibitors.
Sci Rep
; 12(1): 16559, 2022 10 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36192500
20.
Crizotinib efficacy and safety in patients with advanced NSCLC harboring MET alterations: A real-life data of Turkish Oncology Group.
Medicine (Baltimore)
; 101(50): e32368, 2022 Dec 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36550824